- ICH GCP
- Registro de ensayos clínicos de EE. UU.
- Ensayo clínico NCT01863095
An Exercise App to Reduce Young Adults' MJ Use
29 de enero de 2016 actualizado por: R. Lorraine Collins, Ph.D., State University of New York at Buffalo
Use of Exercise to Reduce Young Adult Marijuana Use: There is an App for That
Currently, marijuana (MJ) is the most popular illicit drug, but there are few effective interventions to help young adults (age 18 to 25 years) to reduce their MJ intake.
In this study, we will develop and initially test a smart phone app designed to promote exercise/physical activity as a positive alternative to MJ use.
The app will be tested in an efficacy study in which MJ users are randomly to either receive personalized feedback about MJ use + use the exercise app or personalized feedback only.
The results will contribute to knowledge about exercise/physical activity as a strategy for reducing young adults' MJ use and problems.
Descripción general del estudio
Estado
Terminado
Condiciones
Intervención / Tratamiento
Descripción detallada
Currently, marijuana (MJ) is the most popular illicit drug, with prevalence studies indicating increasing use among young adults (Johnston et al., 2011).
Even so, there are few effective interventions to help MJ users reduce their intake to avoid negative consequences, including MJ dependence.
The investigators propose a Stage 1 efficacy study to develop and initially test an innovative intervention to reduce MJ use among young adults who regularly use MJ (> 3 episodes/week).
The intervention includes elements from the Marijuana Check-Up (MCU; Stephens et al., 2007), a MI-based brief intervention that has shown promise for reducing MJ use.
It also incorporates findings from our ongoing research, which suggest that exercise/physical activity (PA) has potential as a positive alternative to MJ use.
The investigators research also has shown that short (i.e., 10 minute) bouts of moderate or intense exercise reduce craving/urges to use MJ.
Exercise interventions have successfully reduced use of licit substances, such as tobacco (e.g., Marcus et al., 2005) and alcohol (e.g., Brown et al., 2009), but have not been adequately tested for MJ use.
The two aims of this R34 application are: 1) To develop an intervention that consists of four, 60-minute, in-person sessions composed of MCU content (e.g., personalized feedback, MI) as well as a smart phone application (app) that promotes exercise/physical activity (EA) as an alternative to MJ use.
The EA, which will be designed to specifically appeal to young adults, will provide a readily-accessible, flexible, and convenient platform for personalized information and reminders that promote exercise/PA as a positive alternative to MJ use in ongoing daily life.
2) To conduct a pilot/efficacy study of the 4-week MCU+EA intervention vs. a MCU-only control condition.
The investigators will use urn randomization to assign emerging/young-adult MJ users (N = 40) to the two conditions.
During the 1-week baseline, 4-week intervention phase, and 1-, 3-, and 6-month follow-ups, all participants will use the smart phone app to provide real-time data on MJ-related variables and wear accelerometers to provide PA data.
Multilevel modeling will be used to test our hypothesis that the MCU+EA intervention, compared to MCU-only control, will produce greater decreases in quantity and frequency of MJ use (and related MJ problems) at post-intervention and at each follow-up.
Multilevel modeling also will be used to explore the real-time data to examine the role of variables such as urge/craving for MJ, social factors, and dosage of PA in the reduction of the quantity and frequency of MJ use.
This Stage 1 study is unique and innovative in its development and use of a smart phone app to promote and evaluate exercise/PA as a positive alternative to MJ use in daily life.
It includes cutting-edge technology (e.g., accelerometers, smart phone app) for real-time assessments.
This research will make significant contributions to the limited knowledge of exercise/PA as a strategy for reducing MJ use and related problems among emerging and young adults.
Tipo de estudio
Intervencionista
Inscripción (Actual)
36
Fase
- No aplica
Contactos y Ubicaciones
Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.
Ubicaciones de estudio
-
-
New York
-
Buffalo, New York, Estados Unidos, 14214
- Center for Health Research
-
-
Criterios de participación
Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.
Criterio de elegibilidad
Edades elegibles para estudiar
18 años a 25 años (Adulto)
Acepta Voluntarios Saludables
No
Géneros elegibles para el estudio
Todos
Descripción
Inclusion Criteria:
- Regular Marijuana user interested in cutting down on marijuana use
- Body Mass Index < 30
Exclusion Criteria:
- Pregnant or planning to become pregnant
- No legal problems
- No substance abuse diagnosis
- No history of substance abuse treatment
- Medical contraindications to engaging in exercise
- Psychological distress or psychiatric treatment
Plan de estudios
Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.
¿Cómo está diseñado el estudio?
Detalles de diseño
- Propósito principal: Prevención
- Asignación: Aleatorizado
- Modelo Intervencionista: Asignación paralela
- Enmascaramiento: Ninguno (etiqueta abierta)
Armas e Intervenciones
Grupo de participantes/brazo |
Intervención / Tratamiento |
---|---|
Experimental: Lifestyle counseling
MJ users assigned to this condition will participate in 4 individualized intervention sessions that are based on Motivational Interviewing principles.
They will receive personalized feedback on their MJ use and will be provided a smart phone app on which they report their MJ use episodes, which also is designed to promote the use of exercise/physical activity as an alternative to MJ use.
Level of Physical activity will be measured using accelerometers.
|
|
Comparador activo: Personalized Feedback only
MJ users assigned to this condition will participate in 4 individualized intervention sessions that are based on Motivational Interviewing principles.
They will only receive personalized feedback on their MJ use.
|
¿Qué mide el estudio?
Medidas de resultado primarias
Medida de resultado |
Medida Descripción |
Periodo de tiempo |
---|---|---|
Physical Activity
Periodo de tiempo: Change in exercise at 1 month, 3 months, and 6 months after interventionts
|
Counts based on data collected by accelerometers.
|
Change in exercise at 1 month, 3 months, and 6 months after interventionts
|
Substance Use
Periodo de tiempo: Change in marijuana use at 1 month, 3 months, and 6 months after intervention
|
Change in marijuana use at 1 month, 3 months, and 6 months after intervention
|
Colaboradores e Investigadores
Aquí es donde encontrará personas y organizaciones involucradas en este estudio.
Patrocinador
Investigadores
- Investigador principal: R Lorraine Collins, Ph.D., State University of New York at Buffalo
Fechas de registro del estudio
Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.
Fechas importantes del estudio
Inicio del estudio
1 de octubre de 2014
Finalización primaria (Actual)
1 de mayo de 2015
Finalización del estudio (Actual)
1 de junio de 2015
Fechas de registro del estudio
Enviado por primera vez
21 de mayo de 2013
Primero enviado que cumplió con los criterios de control de calidad
24 de mayo de 2013
Publicado por primera vez (Estimar)
27 de mayo de 2013
Actualizaciones de registros de estudio
Última actualización publicada (Estimar)
1 de febrero de 2016
Última actualización enviada que cumplió con los criterios de control de calidad
29 de enero de 2016
Última verificación
1 de enero de 2016
Más información
Términos relacionados con este estudio
Términos MeSH relevantes adicionales
Otros números de identificación del estudio
- R34DA035358 (Subvención/contrato del NIH de EE. UU.)
Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .